• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

墨西哥 COVID-19 按性别和年龄组划分的致死风险标志物:基于机器学习方法的横断面研究。

Lethality risk markers by sex and age-group for COVID-19 in Mexico: a cross-sectional study based on machine learning approach.

机构信息

Center for Research on Infectious Diseases, Instituto Nacional de Salud Pública, Cuernavaca, 62100, Mexico.

Instituto de Investigaciones en Matemáticas Aplicadas y en Sistemas, Universidad Nacional Autónoma de México, Mexico City, 04510, Mexico.

出版信息

BMC Infect Dis. 2023 Jan 11;23(1):18. doi: 10.1186/s12879-022-07951-w.

DOI:10.1186/s12879-022-07951-w
PMID:36631853
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9832420/
Abstract

BACKGROUND

Mexico ranks fifth worldwide in the number of deaths due to COVID-19. Identifying risk markers through easily accessible clinical data could help in the initial triage of COVID-19 patients and anticipate a fatal outcome, especially in the most socioeconomically disadvantaged regions. This study aims to identify markers that increase lethality risk in patients diagnosed with COVID-19, based on machine learning (ML) methods. Markers were differentiated by sex and age-group.

METHODS

A total of 11,564 cases of COVID-19 in Mexico were extracted from the Epidemiological Surveillance System for Viral Respiratory Disease. Four ML classification methods were trained to predict lethality, and an interpretability approach was used to identify those markers.

RESULTS

Models based on Extreme Gradient Boosting (XGBoost) yielded the best performance in a test set. This model achieved a sensitivity of 0.91, a specificity of 0.69, a positive predictive value of 0.344, and a negative predictive value of 0.965. For female patients, the leading markers are diabetes and arthralgia. For males, the main markers are chronic kidney disease (CKD) and chest pain. Dyspnea, hypertension, and polypnea increased the risk of death in both sexes.

CONCLUSIONS

ML-based models using an interpretability approach successfully identified risk markers for lethality by sex and age. Our results indicate that age is the strongest demographic factor for a fatal outcome, while all other markers were consistent with previous clinical trials conducted in a Mexican population. The markers identified here could be used as an initial triage, especially in geographic areas with limited resources.

摘要

背景

墨西哥是全球因 COVID-19 死亡人数排名第五的国家。通过易于获取的临床数据识别风险标志物,有助于对 COVID-19 患者进行初步分诊,并预测致命结局,尤其是在社会经济最落后的地区。本研究旨在基于机器学习 (ML) 方法,确定与 COVID-19 患者病死率相关的标志物。这些标志物根据性别和年龄组进行了区分。

方法

从病毒性呼吸道疾病流行病学监测系统中提取了墨西哥共 11564 例 COVID-19 病例。采用四种 ML 分类方法对病死率进行预测,并采用可解释性方法识别这些标志物。

结果

基于极端梯度提升 (XGBoost) 的模型在测试集中表现最佳。该模型的灵敏度为 0.91,特异性为 0.69,阳性预测值为 0.344,阴性预测值为 0.965。对于女性患者,主要标志物是糖尿病和关节痛。对于男性患者,主要标志物是慢性肾脏病 (CKD) 和胸痛。呼吸困难、高血压和呼吸急促增加了两性患者的死亡风险。

结论

使用可解释性方法的基于 ML 的模型成功地按性别和年龄识别了病死率的风险标志物。我们的结果表明,年龄是导致死亡的最强人口统计学因素,而所有其他标志物都与之前在墨西哥人群中进行的临床试验一致。这里确定的标志物可用于初步分诊,尤其是在资源有限的地理区域。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16b5/9832816/54d32f2b77f1/12879_2022_7951_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16b5/9832816/17fbe46bbbbb/12879_2022_7951_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16b5/9832816/a16393dbc9ec/12879_2022_7951_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16b5/9832816/2fe7d05ada87/12879_2022_7951_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16b5/9832816/7196e716c6e1/12879_2022_7951_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16b5/9832816/7ce0ab03d1c2/12879_2022_7951_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16b5/9832816/7bb9dd3df63a/12879_2022_7951_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16b5/9832816/54d32f2b77f1/12879_2022_7951_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16b5/9832816/17fbe46bbbbb/12879_2022_7951_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16b5/9832816/a16393dbc9ec/12879_2022_7951_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16b5/9832816/2fe7d05ada87/12879_2022_7951_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16b5/9832816/7196e716c6e1/12879_2022_7951_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16b5/9832816/7ce0ab03d1c2/12879_2022_7951_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16b5/9832816/7bb9dd3df63a/12879_2022_7951_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16b5/9832816/54d32f2b77f1/12879_2022_7951_Fig7_HTML.jpg

相似文献

1
Lethality risk markers by sex and age-group for COVID-19 in Mexico: a cross-sectional study based on machine learning approach.墨西哥 COVID-19 按性别和年龄组划分的致死风险标志物:基于机器学习方法的横断面研究。
BMC Infect Dis. 2023 Jan 11;23(1):18. doi: 10.1186/s12879-022-07951-w.
2
Predicting Mortality Due to SARS-CoV-2: A Mechanistic Score Relating Obesity and Diabetes to COVID-19 Outcomes in Mexico.预测因 SARS-CoV-2 导致的死亡率:一个将肥胖和糖尿病与墨西哥 COVID-19 结局相关联的机制评分。
J Clin Endocrinol Metab. 2020 Aug 1;105(8). doi: 10.1210/clinem/dgaa346.
3
Risk Factors Associated with COVID-19 Lethality: A Machine Learning Approach Using Mexico Database.与 COVID-19 致死率相关的风险因素:使用墨西哥数据库的机器学习方法。
J Med Syst. 2023 Aug 19;47(1):90. doi: 10.1007/s10916-023-01979-4.
4
Can Predictive Modeling Tools Identify Patients at High Risk of Prolonged Opioid Use After ACL Reconstruction?预测模型工具能否识别 ACL 重建术后阿片类药物使用时间延长的高风险患者?
Clin Orthop Relat Res. 2020 Jul;478(7):0-1618. doi: 10.1097/CORR.0000000000001251.
5
Uncovering Clinical Risk Factors and Predicting Severe COVID-19 Cases Using UK Biobank Data: Machine Learning Approach.利用英国生物库数据揭示临床风险因素并预测严重 COVID-19 病例:机器学习方法。
JMIR Public Health Surveill. 2021 Sep 30;7(9):e29544. doi: 10.2196/29544.
6
Prediction of death status on the course of treatment in SARS-COV-2 patients with deep learning and machine learning methods.利用深度学习和机器学习方法预测 SARS-CoV-2 患者治疗过程中的死亡状态。
Comput Methods Programs Biomed. 2021 Apr;201:105951. doi: 10.1016/j.cmpb.2021.105951. Epub 2021 Jan 22.
7
A data-driven approach to predicting diabetes and cardiovascular disease with machine learning.基于机器学习的数据驱动方法预测糖尿病和心血管疾病。
BMC Med Inform Decis Mak. 2019 Nov 6;19(1):211. doi: 10.1186/s12911-019-0918-5.
8
Risk Factors Associated with COVID-19 Mortality in the State of Durango, Mexico.墨西哥杜兰戈州与 COVID-19 死亡率相关的风险因素。
Int J Med Sci. 2023 May 27;20(8):993-999. doi: 10.7150/ijms.82591. eCollection 2023.
9
Machine Learning Applied to Clinical Laboratory Data in Spain for COVID-19 Outcome Prediction: Model Development and Validation.机器学习在西班牙临床实验室数据中应用于 COVID-19 结局预测:模型的开发和验证。
J Med Internet Res. 2021 Apr 14;23(4):e26211. doi: 10.2196/26211.
10
Comparative Effectiveness of Machine Learning Approaches for Predicting Gastrointestinal Bleeds in Patients Receiving Antithrombotic Treatment.机器学习方法预测抗血栓治疗患者胃肠道出血的效果比较。
JAMA Netw Open. 2021 May 3;4(5):e2110703. doi: 10.1001/jamanetworkopen.2021.10703.

引用本文的文献

1
High nasopharyngeal and serum IL-6 levels and the - 573G > C polymorphism (rs1800796) are linked with the risk of severe COVID-19 in a Mexican population: a case‒control study.高鼻咽和血清白细胞介素-6水平以及-573G>C多态性(rs1800796)与墨西哥人群中重症COVID-19的风险相关:一项病例对照研究。
BMC Infect Dis. 2025 Mar 5;25(1):315. doi: 10.1186/s12879-025-10695-y.
2
A systematic review of Machine Learning and Deep Learning approaches in Mexico: challenges and opportunities.墨西哥机器学习与深度学习方法的系统综述:挑战与机遇
Front Artif Intell. 2025 Jan 7;7:1479855. doi: 10.3389/frai.2024.1479855. eCollection 2024.
3

本文引用的文献

1
Predictors of mortality in hospitalized COVID-19 patients: A Mexican population-based cohort study.住院COVID-19患者的死亡率预测因素:一项基于墨西哥人群的队列研究。
Biomedicine (Taipei). 2021 Jun 1;11(2):1-4. doi: 10.37796/2211-8039.1124. eCollection 2021.
2
Variation in the COVID-19 infection-fatality ratio by age, time, and geography during the pre-vaccine era: a systematic analysis.在疫苗接种前时代,按年龄、时间和地理位置划分的 COVID-19 感染病死率变化:系统分析。
Lancet. 2022 Apr 16;399(10334):1469-1488. doi: 10.1016/S0140-6736(21)02867-1. Epub 2022 Feb 24.
3
[Not Available].
Setting Ranges in Potential Biomarkers for Type 2 Diabetes Mellitus Patients Early Detection By Sex-An Approach with Machine Learning Algorithms.
通过性别设定2型糖尿病患者早期检测潜在生物标志物的范围——一种机器学习算法方法
Diagnostics (Basel). 2024 Jul 27;14(15):1623. doi: 10.3390/diagnostics14151623.
4
Blood ACE2 Protein Level Correlates with COVID-19 Severity.血液 ACE2 蛋白水平与 COVID-19 严重程度相关。
Int J Mol Sci. 2023 Sep 11;24(18):13957. doi: 10.3390/ijms241813957.
5
Vessel-on-a-Chip: A Powerful Tool for Investigating Endothelial COVID-19 Fingerprints.芯片上的血管:研究内皮细胞 COVID-19 特征的有力工具。
Cells. 2023 May 2;12(9):1297. doi: 10.3390/cells12091297.
[无可用内容]
Salud Publica Mex. 2021 Nov 5;63(6, Nov-Dic):725-733. doi: 10.21149/12842.
4
An Analysis COVID-19 in Mexico: a Prediction of Severity.墨西哥 COVID-19 分析:严重程度预测。
J Gen Intern Med. 2022 Feb;37(3):624-631. doi: 10.1007/s11606-021-07235-0. Epub 2022 Jan 7.
5
Detection of COVID-19 by Machine Learning Using Routine Laboratory Tests.基于常规实验室检测的机器学习对 COVID-19 的检测。
Am J Clin Pathol. 2022 May 4;157(5):758-766. doi: 10.1093/ajcp/aqab187.
6
Punt Politics as Failure of Health System Stewardship: Evidence from the COVID-19 Pandemic Response in Brazil and Mexico.将政治视为卫生系统管理失败:来自巴西和墨西哥应对新冠疫情的证据
Lancet Reg Health Am. 2021 Dec;4:100086. doi: 10.1016/j.lana.2021.100086. Epub 2021 Sep 27.
7
Mortality Prediction Utilizing Blood Biomarkers to Predict the Severity of COVID-19 Using Machine Learning Technique.利用血液生物标志物和机器学习技术预测COVID-19严重程度的死亡率预测
Diagnostics (Basel). 2021 Aug 31;11(9):1582. doi: 10.3390/diagnostics11091582.
8
Predicting the Disease Outcome in COVID-19 Positive Patients Through Machine Learning: A Retrospective Cohort Study With Brazilian Data.通过机器学习预测新冠病毒阳性患者的疾病结局:一项基于巴西数据的回顾性队列研究。
Front Artif Intell. 2021 Aug 13;4:579931. doi: 10.3389/frai.2021.579931. eCollection 2021.
9
Disability-Adjusted Life Years for the COVID-19 Pandemic in the Mexican Population.墨西哥人口中与 COVID-19 大流行相关的残疾调整生命年。
Front Public Health. 2021 Aug 17;9:686700. doi: 10.3389/fpubh.2021.686700. eCollection 2021.
10
Machine Learning Approaches to Identify Patient Comorbidities and Symptoms That Increased Risk of Mortality in COVID-19.用于识别增加COVID-19死亡风险的患者合并症和症状的机器学习方法
Diagnostics (Basel). 2021 Jul 31;11(8):1383. doi: 10.3390/diagnostics11081383.